SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending downwards as investors react to increased spending forecasts related to AI, drawing comparisons to the company's metaverse investments; the community is debating whether this dip represents a buying opportunity or signals deeper concerns about Meta's direction, with some citing a one-time tax charge as the primary driver, while others point to overall market weakness or algorithmic reactions.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around the iconic Rage Guy meme, emphasizing a return to OG meme culture and community-driven growth. Discussions highlight the importance of belief and shared effort, with community members expressing bullish sentiment and encouraging each other to "RAGE ON" and "work for their bags". The movement is positioned as a cultural correction against soulless memecoins.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors anticipate the company's earnings report and how effectively it's monetizing data through AI partnerships. Community members are discussing revenue estimates, daily active user growth, and the potential for a post-earnings rally or selloff. Some are also pointing to potential connections with other trending stocks and broader market factors.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle ($CMG) is trending due to a significant drop following a lowered sales outlook, sparking discussions about consumer spending and the company's value proposition. Community members are debating whether the dip is a buying opportunity or a sign of deeper issues with the brand, citing concerns about pricing, portion sizes, and competition in the fast-casual dining sector.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific (CORZ) is trending as shareholders prepare to vote on a proposed merger with CoreWeave ($CRWV); discussions center on whether the deal undervalues CORZ, especially given the potential for AI infrastructure growth. Some shareholders believe CORZ is worth more as a standalone company, citing peers and potential for new contracts, while others worry about financial stability without the merger. The vote outcome is uncertain, leading to speculation about future directions and potential board changes.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

EBS is trending due to raised FY25 EBITDA guidance, sparking optimism about the company's future profitability. The community is discussing the potential for a significant stock re-rating and a short squeeze, with some highlighting the low P/E ratio relative to the broader market. Discussions also involve potential catalysts like government appropriations and debt refinancing.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as community members discuss the potential for a short squeeze, driven by high short interest and optimism around the company's pipeline. Chatter revolves around buyout speculation, comparisons to competitors, and anticipation for upcoming presentations at ObesityWeek. The stock's recent performance and market dynamics in the obesity treatment sector are also fueling the conversation.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending amid unconfirmed rumors of a potential buyout, sparking active discussions within the investment community. The speculation surfaces as the company focuses on oncology and prepares to report earnings in November. Community members are weighing the potential deal price and strategic implications for Moderna's future.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMC is trending as investors digest recent earnings and a reduced dividend, leading to a sharp price decline. The community is debating whether this presents a value opportunity or signals deeper challenges for the company, with some citing an overreaction and oversold conditions. Bullish sentiment is building around potential for a price rebound given its inclusion in the S&P 500.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is trending due to upcoming Phase 3 data for its DMD treatment, with investors closely watching for positive results that could lead to FDA approval; community chatter reflects both excitement and apprehension, as the data represents a pivotal moment for the company. Community members also highlight BlackRock's substantial stake in Capricor. Some traders cite the potential for a significant short squeeze based on the stock's high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Funds advised by BC Partners, Chewy's (CHWY) largest shareholder, are selling $1 billion worth of shares, the pet supplies company said on Monday. The company's stock dropped 2.3% in after-market trading after the company revealed the block trade in an exchange filing.Large sales are typically bad for a stock, as they signal that the selling investor sees little upside.BC Partners funds are selling 23.9 million Class A shares of Chewy at $41.91 per share, according to an exchange filing.Chewy won't receive any proceeds from the sale but has agreed to buy from the BC Partners funds $100 million worth of shares to be canceled upon completion of the deal.Chewy said the buyback was unrelated to its existing $500 million repurchase program, which remains untouched.The sale would reduce BC Partners' economic interest in Chewy to about 47% from about 53%, according to Bloomberg calculations.The investor will be restricted from selling any additional shares of Chewy for 60 days, according to the filing.Retail investors grew cautious. On Stocktwits, the sentiment dropped to 'bearish' as of early Tuesday from 'extremely bullish' a week ago.<figure class="image"><img style="aspect-ratio:1286/134;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_24_at_11_48_09_AM_png_224c1d6d41.webp" alt="Screenshot 2025-06-24 at 11.48.09 AM.png" width="1286" height="134"><figcaption>CHWY sentiment and message volume as of June 24 | Source: Stocktwits</figcaption></figure>A user said the $1 billion stock sale might create "enormous selling pressure" for the stock.<stembedurl>https://stocktwits.com/Buffythepumperslayer/message/618735450</stembedurl>However, another noted that "Chewy isn't diluting shares, it's not raising emergency cash, and the company itself is repurchasing shares, not dumping them."<stembedurl>https://stocktwits.com/Stockrupt/message/618735455</stembedurl>On the business side, Chewy has demonstrated strong financial performance in the last few quarters, indicating business momentum. Its&nbsp;<a href="https://stocktwits.com/symbol/CHWY">shares</a> hit an over two-year high earlier this month and are up nearly 30% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A woman opening online parcels with her dog. (Photo: Edwin Tan via Getty Images)

Chewy Shareholder BC Partners To Sell $1B Shares: Retail Mood Drops

Chewy won't receive any proceeds from the sale but has agreed to buy from the BC Partners funds $100 million worth of shares to be canceled upon completion of the deal.

Equity

Chewy won't receive any proceeds from the sale but has agreed to buy from the BC Partners funds $100 million worth of shares to be canceled upon completion of the deal.


Chewy Inc. (CHWY) issued its first-quarter results and current-quarter forecast on Wednesday, which&nbsp;exceeded Wall Street's expectations. Still, the stock dropped 11%.The slide in shares, their steepest intraday loss in nearly two years, left retail investors confused. Some users on Stocktwits called it an "overreaction" by the market.Chewy has demonstrated strong financial performance in the last few quarters, indicating business momentum. Its&nbsp;<a href="https://stocktwits.com/symbol/CHWY">shares</a> hit an over two-year high earlier this week and are up 21.7% year-to-date.In an investor note released last week, Jefferies acknowledged the business's strength but&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/chewy-analyst-steps-to-sidelines-on-valuation-concerns-retail-agrees/chkzXthRbx0">warned</a> that a high stock multiple and the absence of near-term catalysts would be headwinds. It downgraded its rating to 'Hold' before Chewy's report.Chewy’s otherwise strong first-quarter results showed a 10-basis-point drop in the company's gross margin to 29.6%, likely raising concerns about profitability.One Stocktwits user said, "I don't think the 12% drop we got today is justified. Again, the market overreacted."<stembedurl>https://stocktwits.com/pumma4/message/617628981</stembedurl>Another laid out expectation for a "strong recovery" on Thursday.<stembedurl>https://stocktwits.com/SHTON/message/617628199</stembedurl>The overall retail sentiment shifted to 'extremely bullish' from 'bullish' the day prior. Message volume jumped 287% in the past 24 hours.<figure class="image"><img style="aspect-ratio:1150/130;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_12_at_9_27_53_AM_png_4fabf91550.webp" alt="Screenshot 2025-06-12 at 9.27.53 AM.png" width="1150" height="130"><figcaption>CHWY sentiment and message volume as of June 11 | Source: Stocktwits</figcaption></figure>The pet supplies retailer said net sales increased 8.3% to $3.12 billion in Q1, above analysts' expectations of $3.08 billion.Adjusted earnings of $0.35 per share, also above the expected $0.33.For fiscal Q2, the company expects adjusted earnings of $0.30 to $0.35 per share on net sales of $3.06 billion to $3.09 billion. Analysts expect an adjusted EPS of $0.31 for sales of $3.04 billion."These results are a testament to the resiliency of the pet category and underscore the strength of Chewy's value proposition and our ability to continue to gain market share," CEO Sumit Singh said in a statement.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Chewy Shares Drop Despite Strong Quarterly Results, Forecast: Retail Bets On Quick Recovery

CEO Sumit Singh says the pet segment is resilient, and Chewy will continue to gain market share.

Jefferies downgraded Chewy (CHWY) stock to 'Hold' from 'Buy' on Thursday, citing high valuation and limited near-term upside.The pet supplies retailer has bucked the tariff-driven downturn in the market, with its shares rising nearly 42% year-to-date.In an investor note, Jefferies said the stock trades at 24 times its 2026 EBITDA forecast, over eight times what it was in March, according to The Fly.The current levels&nbsp;factored in strong Q1 results and a guidance raise, which Jefferies thinks are unlikely.&nbsp; The company is scheduled to report its quarterly results on June 11, before the market opens.The investment advisor noted the pet supplies sector remains relatively stable, with Chewy performing solidly. A CFO transition is underway, and much of the upside appears to be priced into the stock.Still, Jefferies noted a lack of near-term catalysts, pointing to modest growth in pet-owning households and U.S. consumer spending.It raised its price target on the stock to $43 from $41. The&nbsp;updated target is 9.5% lower than the current stock price of $47.49.On Stocktwits, the retail sentiment for the company's shares dropped to 'neutral' from 'bullish' the previous day.<figure class="image"><img style="aspect-ratio:634/68;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_06_at_8_34_28_AM_png_62b0117923.webp" alt="Screenshot 2025-06-06 at 8.34.28 AM.png" width="634" height="68"><figcaption>CHWY sentiment and message volume as of June 5 | Source: Stocktwits</figcaption></figure>A user suggested that the stock is still worth buying as long as it trades above $40.<stembedurl>https://stocktwits.com/Crazybirdguy/message/616890966</stembedurl>In recent months, Chewy has expanded its product offerings by launching pet wellness brand Oh Norman! and raw food brand Maev on its platform.&nbsp;Additionally, Chewy refreshed its retail media network, Chewy Ads, to enhance advertising solutions for pet brands.<a href="https://stocktwits.com/symbol/CHWY">Chewy shares</a> are up 110% over the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Chewy Analyst Steps To Sidelines On Valuation Concerns — Retail Agrees

The pet supplies retailer has bucked the tariff-driven downturn in the market, with its shares rising nearly 42% year-to-date.

Retail interest in Chewy, Inc (CHWY) climbed higher on Wednesday after the pet products retailer reported better-than-expected quarterly results and forecasted a strong year.The e-commerce firm projected full-year net sales in the range of $12.3 billion to $12.45 billion, up 6% to 7% year over year. That is broadly in line with a FactSet estimate of $12.38 billion and compares to a 6.4% growth in the prior year.In Q4, net sales rose 15% to $3.25 billion, topping the consensus estimate of $3.2 billion. Adjusted earnings per share rose to $0.28 from $0.18 a year earlier and also beat the target of $0.21."Our performance was underpinned by strong active customer growth, and compelling Autoship customer loyalty," CEO Sumit Singh said.On the analyst call, Singh said that Chewy sees "minimal price inflation," signaling that the business might be more insulated from macro factors than other retailers.Chewy has been navigating a competitive pet e-commerce market, benefiting from strong customer loyalty and subscription-based offerings.Its Autoship program, which allows users to schedule recurring deliveries of pet supplies, has supported sales growth in the past few quarters.&nbsp;Last year, the company also ventured into veterinary practice with the launch of pet clinics.CHWY shares ended 1.1% lower at $33.25 on Wednesday amid a selloff in the broader market.Barclays raised its price target on the company's shares to $44 from $40, reiterating its 'overweight' rating. Mizuho raised its PT by $1 to $43 and maintained its 'outperform' rating.Both investment advisors noted that Chewy's outlook, which likely includes some conservatism from macro headwinds and tariffs, is attractive.Barclays said the company is one of the top names to watch in the e-commerce sector.On Stocktwits, retail sentiment for CHWY climbed higher in the 'extremely bullish' category, while message volume remained 'extremely high.'<img src="https://news.stocktwits-cdn.com/Screenshot_2025_03_27_at_8_03_19_AM_png_868fc0eb55.webp" alt="Screenshot 2025-03-27 at 8.03.19 AM.png">A user reiterated the business's resilience: "Most folks will feed their pet before they feed themselves."<stembedurl>https://stocktwits.com/ruck_my_life/message/609293909</stembedurl>Another user noted that watchers for the stock grew by a couple of hundreds.<stembedurl>https://stocktwits.com/Crazybirdguy/message/609308574</stembedurl>CHWY shares are down 0.7% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Retail Bulls Bite Into Chewy Stock As Q4 Results, 2025 Outlook Impress Amid Market Selloff

Chewy’s Autoship program, which allows users to schedule recurring deliveries of pet supplies, has supported sales growth in the past few quarters. Last year, the company also launched pet clinics.

Chewy, Inc (CHWY) shares fell 1.2% on Tuesday, ahead of its fourth-quarter earnings report before the markets open the next day.The online retailer of pet food and pet-related products is expected to report adjusted sales of $3.2 billion, 13% higher than the year-ago quarter, according to estimates from Koyfin.Adjusted earnings per share is estimated to rise 13.8% to $0.20.Chewy has been navigating a competitive pet e-commerce market, benefiting from strong customer loyalty and subscription-based sales but facing challenges from slowing consumer spending and rising costs.The company has of late focused on expanding its product offerings.Chewy is pushing to grow its Autoship program, which allows users to schedule recurring deliveries of pet supplies. Last year, it ventured into veterinary practice with the launch of pet clinics.Owing to some of these initiatives, the company in December&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.retaildive.com/news/chewy-raises-full-year-guidance-beats-third-quarter-expectations/734687/#:~:text=Looking%20ahead%2C%20Chewy%20raised%20its,from%204.5%25%20to%204.7%25.">raised</a> its sales and core profit forecast for 2024.In recent months, Morgan Stanley raised its price target on the company's shares to $40 from $38, and Evercore ISI bumped the rating to 'outperform'.On Stocktwits, the sentiment for CHWY jumped to 'extremely bullish' from 'bullish' a day prior, and message volume rose 177%.<figure class="image"><img style="aspect-ratio:715/164;" src="https://news.stocktwits-cdn.com/Screenshot_2025_03_26_at_11_35_45_AM_png_cbed316756.webp" alt="Screenshot 2025-03-26 at 11.35.45 AM.png" width="715" height="164"><figcaption>CHWY sentiment and message volume as of March 25, 2025 | Source: Stocktwits</figcaption></figure>A user noted increased retail attention in the stock in the past week, while another said Chewy is one of the retailers immune to Donald Trump's recent trade tariffs.<stembedurl>https://stocktwits.com/Jaypicks/message/609239889</stembedurl><stembedurl>https://stocktwits.com/FredrickNietzche/message/609199671</stembedurl>CHWY shares ended at $33.61 on Tuesday, similar to the price level at the start of the year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Chewy Stock Slips Ahead Of Q4 Print, Retail Bets Pet Care Stays Shielded From Trump Tariffs

Chewy has been navigating a competitive pet e-commerce market, benefiting from strong customer loyalty and subscription-based sales but facing challenges from slowing consumer spending and rising costs.

How Is Zoetis’ Stock Performance Compared to Other Pet Care Stocks?

Zoetis has notably lagged behind other pet care stocks over the past year, yet analysts remain strongly bullish on the stock’s prospects.

Do Wall Street Analysts Like IDEXX Laboratories Stock?

IDEXX Laboratories has significantly outperformed the broader market in 2025 and analysts remain bullish on the stock’s prospects.

Petco Health &amp; Wellness Co. ($WOOF) stock was down nearly 3% on Thursday ahead of the pet products retailer’s third-quarter earnings, but retail sentiment turned bullish.Wall Street analysts expect earnings per share to come in at -$0.04 on estimated revenues of&nbsp;$1.5 billion. Petco has beaten estimates thrice out of the last four quarters.Recently, analyst firm Baird reiterated its ‘Neutral’ rating on the company and maintained its price target of $5.00.The company has previously said it expects Q3 net revenues to be around $1.5 billion; and adjusted earnings before interest, taxes, and depreciation to be between $76 million and $80 million. Its guidance for adjusted EPS stands at -$0.03 to -$0.04.Retail sentiment on Stocktwits has turned ‘bullish’ (67/100) from ‘bearish’ (43/100) a week ago.In the second quarter, Petco met revenue consensus estimates. It posted net revenues of $1.52 billion, down 0.5% compared to the prior year. Overall, the quarter was a mixed bag. It beat estimates on EPS estimates but lowered guidance for the next quarter.Last month, Petco named Joe Venezia Chief Revenue Officer.One Stocktwits user’s analysis of the options market is expecting the stock to move more than 20% following its earnings report.<stembedurl>https://stocktwits.com/Olddrache/message/595191636</stembedurl><a href="https://stocktwits.com/symbol/WOOF">Petco stock</a> is up 55% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;&nbsp;

Recently, analyst firm Baird reiterated its ‘Neutral’ rating| Image source: Wikimedia Commons

Petco Stock In Focus Ahead of Q3 Earnings: Retail’s Bullish 

Retail sentiment on Stocktwits has turned ‘bullish' from 'bearish' a week ago

PAWZ
ProShares Pet Care ETF

Latest PAWZ News

PAWZProShares Pet Care ETF

Latest PAWZ News

PAWZ
ProShares Pet Care ETF